Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Cochlear Limited
  6. Summary
    COH   AU000000COH5

COCHLEAR LIMITED

(COH)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
09/10/2021 09/13/2021 09/14/2021 09/15/2021 09/16/2021 Date
232.72 231.2 230 234.72 238.12 Last
132647 108571 124840 124405 175860 Volume
-1.69% -0.65% -0.52% +2.05% +1.45% Change
Estimated financial data (e)
Sales 2022 1 662 M 1 215 M 1 215 M
Net income 2022 280 M 205 M 205 M
Net cash position 2022 559 M 409 M 409 M
P/E ratio 2022 56,1x
Yield 2022 1,28%
Sales 2023 1 849 M 1 352 M 1 352 M
Net income 2023 325 M 237 M 237 M
Net cash position 2023 618 M 452 M 452 M
P/E ratio 2023 48,2x
Yield 2023 1,52%
Capitalization 15 675 M 11 417 M 11 461 M
EV / Sales 2022 9,09x
EV / Sales 2023 8,14x
Nbr of Employees 4 000
Free-Float 99,6%
More Financials
Company
Cochlear Limited is an Australian-based company, which provides implantable hearing solutions. The Company designs and offers products and accessories for adults or children. The Company operates through three geographical segments: Americas, EMEA and Asia Pacific. Its products offer various ways to hear, such as automatically adjusting hearing to different environments and streaming sound from a smartphone. It... 
More about the company
Ratings of Cochlear Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about COCHLEAR LIMITED
09/14SONOVA INVESTOR & ANALYST DAY 2021 : Entering a new phase from a position of str..
DJ
09/08SENSORION : Cochlear to Start Pilot Study of Hearing Preservation Drug
MT
09/08Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing ..
CI
08/23COCHLEAR : Hearing Health Today podcast set for return after 4,000+ tune in
PU
08/19Cochlear Limited Provides Earnings Guidance for the Fiscal Year 2022
CI
08/19Cochlear Limited Declares Ordinary Fully Paid Dividend for the Six Months End..
CI
07/19Cochlear Limited Announces Board Changes
CI
07/15EQS-ADHOC : Sonova to strengthen business unit leadership on the Management Boar..
DJ
07/07Australian shares close at 2-week high on IT, health stocks boost
RE
05/31COCHLEAR : Promotes Non-Executive Director to Chairman
MT
05/31Cochlear Limited Announces Executive Changes
CI
05/14APPLIED GENETIC TECHNOLOGIES : Otonomy's OTO-825 Gene Therapy Saves Hearing Loss..
MT
05/09VIRTUS HEALTH : Names CFO
MT
05/03New Cochlear CoPilot app to help adults improve hearing outcomes through skil..
CI
03/31Australia shares notch best month in four as China data lifts rebound bets
RE
More news
News in other languages on COCHLEAR LIMITED
09/08SENSORION : début des essais sur un candidat-médicament
09/08Sensorion et Cochlear vont lancer une étude pilote sur un médicament destiné ..
08/20MÄRKTE ASIEN/Talfahrt in Hongkong geht weiter - Autoaktien stark unter Druck
08/20MÄRKTE ASIEN/Rasante Talfahrt in Hongkong geht weiter
08/19Cochlear Limited fournit des prévisions de bénéfices pour l'exercice 2022
More news
Chart COCHLEAR LIMITED
Duration : Period :
Cochlear Limited Technical Analysis Chart | COH | AU000000COH5 | MarketScreener
Technical analysis trends COCHLEAR LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 238,12 AUD
Average target price 225,14 AUD
Spread / Average Target -5,45%
EPS Revisions
Managers and Directors
Diggory William Howitt President, CEO, Executive Director & MD
Stuart Sayers Chief Financial Officer & President-Services
Catriona Alison Deans Chairman
Jan Janssen Chief Technology Officer
David Hackshall Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
COCHLEAR LIMITED25.99%11 409
STRAUMANN HOLDING AG85.51%32 901
SONOVA HOLDING AG66.96%26 222
DEMANT A/S48.25%13 502
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.49.23%4 203
ÖSSUR HF.-5.06%3 071